Market Drivers and Segment Insights in the UK Myasthenia Gravis Industry
The UK Myasthenia Gravis Market is propelled by significant drivers including government initiatives and funding, rising incidence of myasthenia gravis, and advancements in research and development. With the market projected to grow from USD 67.68 million in 2025 to USD 143.58 million by 2035 at a CAGR of 7.81%, understanding the key drivers and segment dynamics is essential for stakeholders....
0 Комментарии 0 Поделились 2 Просмотры 0 предпросмотр